Download Curriculum vitae - updated 28.05.2015

Curriculumvitae-updated28.05.2015
Troels Holz Borch, MD
(Formerly Troels Holz Hansen, married July 2013)
Working address:
Herlev University Hospital
Center for Cancer Immune Therapy, Department of Hematology and Department of Oncology,
Herlev Ringvej 75,
2730 Herlev, Denmark.
Email: [email protected]
Phone: +45 38 68 17 56
Fax: +45 38 68 41 53
Date of birth: 30th of December, 1983.
Education and scientific employments
Current position:
(since sep 2014)
Ph.D. student at Center for Cancer Immunotherapy and Department of Oncology,
Herlev University Hospital, University of Copenhagen. Principal investigator of a
phase I/II clinical trial and co-investigator of a multinational multicenter phase III
clinical trial.
Title of Ph.D. project: “Evaluation of immune responses to dendritic cell
vaccination and adoptive cell transfer”.
Aug 2013 – Aug 2014: Clinical research assistant, CCIT/Dept. of Oncology, Herlev Hospital, Copenhagen.
Main focus have been working with T-cell therapy. During the employment I have
gained practical GCP experience working with clinical trials and learning from
colleagues.
2013:
Authorization for independent medical practise – Authorization ID 09G1V.
2012:
Cand.med., Faculty of Health Sciences, University of Copenhagen. Master’s thesis
title: Evaluation of vaccine-specific immune response in patients with metastatic
melanoma or breast cancer treated with dendritic cells transfected with survivin,
hTERT and p53 mRNA.
2010:
Pregraduate Research Education, CCIT, Herlev Hospital, Copenhagen. Main focus
on learning laboratory techniques associated to immune monitoring.
2008:
Bach.med., Faculty of Health Sciences, University of Copenhagen. Bachelor’s
thesis title: Dendritic Cell Vaccination in Malignant Melanoma.
Clinical employments
July 2013 Feb 2013 – July 2013
Feb 2013 Aug 2012 – Jan 2013
Feb 2010 – Jan 2011
Consultant, Psychiatric Emergency Room, Roskilde.
Psychiatric Emergency Room, Roskilde and outpatient psychiatric department
Køge – Medical internship 2nd half
Medical substitute, Emergency Room, Køge Sygehus
Emergency Room, Køge Sygehus – Medical internship 1st half
Pregraduate Research Education, CCIT, Herlev Hospital, Copenhagen
Research courses
April 2015
April 2015
March 2014
August 2013
Annual PhD Course in Oncology (2 day course, 1,6 ECTS points)
Responsible Conduct in Research (2 day course, 2 ECTS points)
Good Clinical Pratice course (1 day). Dept. of Oncology, Herlev Hospital
IMTAC Summer School in Tumor Immunology, Stockholm
Oral presentations and teaching
2015
2014
Poster presentation, Danish Society of Clinical Oncology, 11th annual meeting
Borch TH, Andersen R, Kongsted P, Pedersen M, Met Ö, Andersen MH, thor
Straten P, Donia M, Svane IM. “T-cell therapy in combination with vemurafenib in
BRAF mutated metastatic melanoma patients”.
Poster presentation, Society for Immunotherapy of Cancer, 29th annual meeting,
Washington.
Borch TH, Andersen R, Kongsted P, Pedersen M, Met Ö, Andersen MH, thor
Straten P, Donia M, Svane IM. “T-cell therapy in combination with vemurafenib in
BRAF mutated metastatic melanoma patients”.
2014
Oral presentation, Nordic Melanoma Group meeting, Turku, Finland.
Borch TH, Engell-Noerregaard L, Iversen TZ, Ellebaek E, Met Ö, Andersen MH,
thor Straten P, Svane IM. “Dendritic cells transfected with mRNA for p53,
surviving and hTERT as treatment for patients with advanced malignant melanoma
– a phase I trial”.
2014
Teaching at FALGON 2014 Ph.D. course on the subject “Immune therapy based on
tumor-infiltrating lymphocytes”.
Poster presentation, Society for Immunotherapy of Caner, 25th annual meeting,
Washington.
2010
Other academic activites
Nordic Melanoma Group meeting, Turku, 2014.
American Society of Clinical Oncology, annual meeting, Chicago, 2014.
Danish Society of Clinical Oncology, annual meeting, Nyborg 2014.
EUmeet at Gustave Roussy Institute, Paris, 2013.
Danish Cancer Society Symposium, Copenhagen, 2013.
Society for Melanoma Research, 10th international congress, Philadelphia 2013.
The Danish Cancer Research Society, annual meeting, 2010.
SiTC (formerly known as iSBTc), 25th annual meeting, Washington, 2010.
Docent at Bodies exhibition in Copenhagen, 2008.
Memberships
Danish Society of Clinical Oncology (DSKO)
Danish Medical Association
Foreningen af yngre onkologer (FYO)
American Society of Clinical Oncology (ASCO)
Publications
Engel-Noerregaard L, Hansen TH, Andersen MH, Thor Straten P, Svane IM. Review of clinical studies on
dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between
clinical response and vaccine parameters. Cancer Immunol.Immunother. Jan 2009; 58(1):1-14.
Engel-Noerregaard L, Ellebaek E, Zeeberg-Iversen T, Hansen TH et al. Influence of metronomic
Cyclophosphamide and interleukine-2 alone and in combination on blood regulatory T cells in patients with
advanced malignant melanoma treated with dendritic cell vaccines. J Clin Cell Immunol 2012, 3:118.